Skip to main content
SpringerLink
Log in

Inotropa

  • Chapter
Anästhesie in Frage und Antwort

  • 30 Accesses

Zusammenfassung

Herzglykoside und Phosphodiesterase-III-Hemmstoffe beim Herzinsuffizienten

  1. 1.

    erhöhen die Herzfrequenz

  2. 2.

    erhöhen den „cardiac output“ (CO)

  3. 3.

    erweitern direkt die Gefäße

  4. 4.

    erhöhen den Pulmonalarteriendruck

  5. 5.

    erhöhen den myokardialen O2-Verbrauch (MVO2)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Barash PG, Cullen BF, Stoelting RK (1989) Clinical anesthesia. Lippincott, Philadelphia, pp 207–208

    Google Scholar 

  • Dorigo P, Santostasi G, Fraccarollo D, Maragno I (1994) Inotropic agents in development. Exp Opin Invest Drugs 3: 457–468

    Article  CAS  Google Scholar 

  • Hines RL (1995) New cardiotonic agents. ASA Annual Refresher Course Lectures, Atlanta, #215

    Google Scholar 

  • Kaufmann MA, Pargger H (1994) Role of PDE-inhibitors in acute myocardial contractile failure. Anaesth Pharmacol Rev 2: 324–331

    Google Scholar 

  • Monk CR (1993) Phosphodiesterase inhibitors. Curr Anaesth Crit Care 4: 152–156

    Article  Google Scholar 

  • Rutman HI, LeJemtel TH, Sonnenblick EH (1987) Newer cardiotonic agents: implications for patients with heart failure and ischaemic heart disease. J Cardiothorac Anesth 1: 59–70

    Article  PubMed  CAS  Google Scholar 

  • Smith TW (1988) Digitalis: mechanism of action and clinical use. N Engl J Med 6: 358–365

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fakultät für Klinische Medizin Mannheim, Universität Heidelberg, Maybachstraße 14-16, D-68169, Mannheim, Deutschland

    Priv.-Doz. Dr. med. Georg Petroianu

  2. Institut für Pharmakologie und Toxikologie, Maybachstraße 14-16, D-68169, Mannheim, Deutschland

    Priv.-Doz. Dr. med. Georg Petroianu

  3. Institut für Anästhesiologie und operative Intensivmedizin, Stadtkrankenhaus Hanau, Leimenstraße 20, D-63450, Hanau, Deutschland

    Prof. Dr. med. Peter Michael Osswald

  4. Akademisches Lehrkrankenhaus, Johann-Wolfgang-Goethe-Universität Frankfurt, Leimenstraße 20, D-63450, Hanau, Deutschland

    Prof. Dr. med. Peter Michael Osswald

Authors
  1. Priv.-Doz. Dr. med. Georg Petroianu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Peter Michael Osswald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Petroianu, G., Osswald, P.M. (1997). Inotropa. In: Anästhesie in Frage und Antwort. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05716-2_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05716-2_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62438-7

  • Online ISBN: 978-3-662-05716-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation